Alnylam Pharmaceuticals Inc. (ALNY)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Alnylam Pharmaceuticals Inc. (ALNY)
12 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on ALNY
- Ohad Hammer(3)
- Mike Havrilla(3)
- Centient Biotech Investor(3)
- ChinaBio Today(2)
- Eben Tessari (2)
Most popular authors
(tracked in watchlists)
- Andrew Wilkinson(398)
- Stockerblog (201)
- Mike Havrilla(159)
- Don Dion(130)
- Mike Huckman(75)
Most commented on authors
- Ohad Hammer(17)
- Michael Steinberg (7)
- Derek Lowe(7)
- Michael Shulman(5)
- Mike Havrilla(3)
- 'When There's Blood in the Streets', Buy Biotech Stocks
- Isis Pharmaceuticals Panic Overdone
- Alnylam and RNAi: The Truth Hurts
- RNA Interference Stocks: Invest At Your Own Risk
- Investing in miRNA: Beware the Hype, Follow the Money
- Even Fatter Yields for Pfizer; M&A Targets in the Sector
- Can MicroRNA Reverse Heart Disease?
- 2007 Biotech Performance Review
- Six Significant Gene Therapy Stocks
- Alnylam Pharmaceuticals: A Falling Star
- Biotech Day In Review: CuraGen Gets $155 Million For Gene Sequence Division
- Can Takeda (or Roche, or Merck, or...) Afford to Ignore RNAi?
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »